EUVIMEDEUVIMED entdecken
Studienprotokoll

Stage I epithelial or stromal type Wilms tumors are low risk tumors: An analysis of patients treated on the SIOP‐WT‐2001 protocol in the UK‐CCLG and GPOH studies (2001–2020)

Ellen D'Hooghe iD, Rhoikos Furtwängler iD, Tanzina Chowdhury iD, Christian Vokuhl iD, Reem Al-Saadi iD, Kathy Pritchard-Jones iD, Norbert Graf iD, Gordan M Vujanić iD

Cancer · 2023

DOI: 10.1002/cncr.34734 ↗

Kurz gefasst

Studienprotokoll in der Zeitschrift Cancer, 2023. Verfasst von Ellen D'Hooghe und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Oslo University Hospital, Rikshospitalet, Oslo, Norway. Hauptthemen laut MEDLINE: Kidney Neoplasms, Wilms Tumor. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 36 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Patients treated with preoperative chemotherapy with stage I intermediate‐risk Wilms tumor (IR‐WT) represent the largest group of patients with Wilms tumor (WT), and they have excellent outcomes.

Methods

The authors performed a retrospective analysis of patients with stage I epithelial (ET‐WT) or stromal type WT (ST‐WT) treated pre‐ and postoperatively according to the International Society of Paediatric Oncology‐WT‐2001 protocol in the UK Children's Cancer and Leukaemia Group and Gesellschaft für Pädiatrische Onkologie und Hämatologie groups' participation in the relevant WT trials and studies (2001–2020).

Results

There were 880 patients with stage I IR‐WT, including 124 with ET‐WT, 156 with ST‐WT, and 600 with other IR‐WT (oIR‐WT). Patients with stage I ET‐WT or ST‐WT were significantly younger than patients with oIR‐WT, represented a large proportion of stage I WTs in their groups, and tumors showed poor histologic response to preoperative chemotherapy. The 5‐year event‐free survival (EFS) estimates for patients with stage I ET‐WT (96.8% ± 1.8 SE) or ST‐WT (96.8% ± 1.6 SE) were significantly better than for patients with oIR‐WT (90.3% ± 1.3 SE) ( p = .014 and p = .009, respectively). A multivariate analysis showed that histologic type (ET‐WT or ST‐WT) remained a significant factor for EFS when adjusted for age and gender ( p = .032 and p = .022, respectively). In both groups, relapses occurred in 3.2% of patients, and the overall survival was 99.2%.

Conclusions

The results suggest that stage I ET‐WT or ST‐WT could be regarded as low‐risk WT, for which omission of postoperative chemotherapy should be considered. Plain Language Summary Patients with pretreated intermediate‐risk Wilms tumor (WT) represent the largest group of patients with WT. This study reports the outcomes of patients with stage I epithelial type (ET‐WT) or stromal type WT (ST‐WT). These patients were significantly younger and had a larger proportion of stage I cases than patients with other intermediate‐risk WT (oIR‐WT). The event‐free survival for patients with stage I ET‐WT and ST‐WT was significantly better than for patients with oIR‐WT. Rare relapses were curable resulting in 99.2% overall survival.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Kidney NeoplasmsWilms TumorChildHumansInfantRetrospective StudiesNeoplasm StagingNeoplasm Recurrence, LocalAntineoplastic Combined Chemotherapy ProtocolsUnited Kingdom

Stichwörter der Autor:innen

Wilms tumorepithelial or stromal typeoutcomesstage I

Autor:innen und Institutionen

  • Department of Pathology, Oslo University Hospital, Rikshospitalet, Oslo, Norway.
  • Department of Paediatric Haematology and Oncology, Saarland University Hospital, Homburg, Germany.
  • Department of Haematology and Oncology, Great Ormond Street Hospital for Children NHS Foundation Trust, London, UK.
  • Department of Pathology, Division of Paidopathology, University of Bonn, Bonn, Germany.
  • UCL Great Ormond Street Institute of Child Health, London, UK.
  • Histopathology Department, Great Ormond Street Hospital for Children NHS Foundation Trust, London, UK.

ORCID-Profile: Ellen D'Hooghe, Rhoikos Furtwängler, Tanzina Chowdhury, Christian Vokuhl, Reem Al-Saadi, Kathy Pritchard-Jones, Norbert Graf, Gordan M Vujanić

Zitieren

APA

D'Hooghe, E., Furtwängler, R., Chowdhury, T., Vokuhl, C., Al-Saadi, R., Pritchard-Jones, K., Graf, N., & Vujanić, G. M. (2023). Stage I epithelial or stromal type Wilms tumors are low risk tumors: An analysis of patients treated on the SIOP‐WT‐2001 protocol in the UK‐CCLG and GPOH studies (2001–2020). Cancer. https://doi.org/10.1002/cncr.34734

Vancouver

D'Hooghe E, Furtwängler R, Chowdhury T, Vokuhl C, Al-Saadi R, Pritchard-Jones K, et al. Stage I epithelial or stromal type Wilms tumors are low risk tumors: An analysis of patients treated on the SIOP‐WT‐2001 protocol in the UK‐CCLG and GPOH studies (2001–2020). Cancer. 2023. doi:10.1002/cncr.34734

BibTeX
@article{DHooghe2023,
  author = {D'Hooghe, Ellen and Furtwängler, Rhoikos and Chowdhury, Tanzina and Vokuhl, Christian and Al-Saadi, Reem and Pritchard-Jones, Kathy and Graf, Norbert and Vujanić, Gordan M},
  title = {Stage I epithelial or stromal type Wilms tumors are low risk tumors: An analysis of patients treated on the SIOP‐WT‐2001 protocol in the UK‐CCLG and GPOH studies (2001–2020)},
  journal = {Cancer},
  year = {2023},
  doi = {10.1002/cncr.34734}
}
Kostenlos starten →